Vijay Lathi is a Managing Director focused on information convergence and diagnostics investments. Vijay’s investment activity covered a range of healthcare technologies including HCIT, diagnostics and therapeutic platforms, and was the founding investor in both Ilypsa (sold to Amgen) and Relypsa (RLYP).
Justin brings to Eclipse a deep understanding of translating basic science into successful commercial operations. His passion for full-stack investing stems from the belief that disparate hardware and software creates significant frictio...
John Carlson joined Flex in 2016 to lead the Health Solutions business segment where he has refined the medical strategy and sharpened the value proposition resulting in record level bookings in each of the last 3 years. He has built a ...
Before joining BrightInsight, Kal was CCO for Doctor on Demand, founded and led Amgen’s Digital Health Business Unit and was also the Global Marketing Lead for Amgen’s Enbrel™. He has held various Commercial Leadership roles at Novartis and was a Principal with BCG. He remains a Senior Advisor in Digital Health to BCG.
Dr. Edelman is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California at San Diego (UCSD) the Veterans Affairs (VA) Healthcare System of San Diego, and the director of the Diabetes Care Clinic, VA Medical Center.
Dr. Arturo Loaiza-Bonilla is the current Vice Chairman of the Department of Medical Oncology at Cancer Treatment Centers of America, Chief of Medical Oncology and Medical Director of Research at CTCA–Philadelphia, and Co-Founder and Chief Medical Officer at Massive Bio.
Dr. Elliott is on faculty at NYU Langone Health and is a national spokesperson for the American College of Allergy, Asthma, and Immunology. She is a nationally-recognized leader in telemedicine, serving as first author for a position paper on telemedicine for Allergists.
Dr. Mintu P. Turakhia is an Associate Professor and the Executive Director at the Center for Digital Health at Stanford University School of Medicine. He is a cardiac electrophysiologist, outcomes researcher, and clinical trialist.